Revenue Summary of Kane Biotech Inc.

Kane Biotech Inc.'s latest annual revenue in 2023 was 148.98 Thousand CAD , down -94.42% from previous year.
Kane Biotech Inc.'s latest quarterly revenue in 2024 Q2 was 620.43 Thousand CAD , up 1095.77% from previous quarter.
Kane Biotech Inc. reported a annual revenue of 2.66 Million CAD in annual revenue 2022, up 65.97% from previous year.
Kane Biotech Inc. reported a annual revenue of 1.6 Million CAD in annual revenue 2021, up 19.84% from previous year.
Kane Biotech Inc. reported a quarterly revenue of 620.43 Thousand CAD for 2024 Q2, up 1095.77% from previous quarter.
Kane Biotech Inc. reported a quarterly revenue of 148.98 Thousand CAD for 2023 FY, down -94.42% from previous quarter.

Annual Revenue Chart of Kane Biotech Inc. (2023 - 2003)

Historical Annual Revenue of Kane Biotech Inc. (2023 - 2003)

Year	Revenue	Revenue Growth
2023	148.98 Thousand CAD	-94.42%
2022	2.66 Million CAD	65.97%
2021	1.6 Million CAD	19.84%
2020	1.34 Million CAD	-20.78%
2019	1.69 Million CAD	234.51%
2018	506.27 Thousand CAD	-51.1%
2017	1.03 Million CAD	322.99%
2016	244.75 Thousand CAD	133.94%
2015	104.62 Thousand CAD	149.71%
2014	41.89 Thousand CAD	-73.8%
2013	159.94 Thousand CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	-100.0%
2007	17.15 Thousand CAD	-28.81%
2006	24.09 Thousand CAD	8.97%
2005	22.11 Thousand CAD	64.87%
2004	13.41 Thousand CAD	-82.5%
2003	76.64 Thousand CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	51.88 Thousand CAD	104.11%
2024 Q2	620.43 Thousand CAD	1095.77%
2023 FY	148.98 Thousand CAD	-94.42%
2023 Q3	717.85 Thousand CAD	9.21%
2023 Q1	677.61 Thousand CAD	-2.03%
2023 Q2	657.31 Thousand CAD	-3.0%
2023 Q4	-1.26 Million CAD	-275.73%
2022 Q2	839.57 Thousand CAD	48.48%
2022 Q4	691.65 Thousand CAD	20.98%
2022 FY	2.66 Million CAD	65.97%
2022 Q1	565.43 Thousand CAD	37.34%
2022 Q3	571.68 Thousand CAD	-31.91%
2021 Q2	278.74 Thousand CAD	-25.87%
2021 Q1	376.03 Thousand CAD	46.13%
2021 FY	1.6 Million CAD	19.84%
2021 Q3	541.3 Thousand CAD	94.2%
2021 Q4	411.69 Thousand CAD	-23.94%
2020 Q2	267.49 Thousand CAD	-41.36%
2020 Q1	456.13 Thousand CAD	-19.14%
2020 Q4	257.33 Thousand CAD	-28.64%
2020 FY	1.34 Million CAD	-20.78%
2020 Q3	360.6 Thousand CAD	34.81%
2019 Q2	221.29 Thousand CAD	-64.38%
2019 Q4	564.13 Thousand CAD	96.68%
2019 FY	1.69 Million CAD	234.51%
2019 Q3	286.83 Thousand CAD	29.62%
2019 Q1	621.25 Thousand CAD	199.0%
2018 Q4	207.77 Thousand CAD	89.25%
2018 Q2	95.81 Thousand CAD	2.79%
2018 FY	506.27 Thousand CAD	-51.1%
2018 Q3	109.79 Thousand CAD	14.59%
2018 Q1	93.21 Thousand CAD	-87.77%
2017 Q4	762.22 Thousand CAD	1255.14%
2017 Q3	56.24 Thousand CAD	-45.21%
2017 Q2	102.65 Thousand CAD	-10.09%
2017 FY	1.03 Million CAD	322.99%
2017 Q1	114.17 Thousand CAD	53.01%
2016 Q4	74.61 Thousand CAD	25.88%
2016 Q1	37.01 Thousand CAD	61.84%
2016 FY	244.75 Thousand CAD	133.94%
2016 Q3	59.27 Thousand CAD	-19.72%
2016 Q2	73.84 Thousand CAD	99.48%
2015 Q3	11.51 Thousand CAD	-69.44%
2015 Q4	22.87 Thousand CAD	98.7%
2015 FY	104.62 Thousand CAD	149.71%
2015 Q2	37.67 Thousand CAD	15.67%
2015 Q1	32.56 Thousand CAD	40.05%
2014 Q1	- CAD	-100.0%
2014 Q2	- CAD	0.0%
2014 Q3	18.64 Thousand CAD	0.0%
2014 FY	41.89 Thousand CAD	-73.8%
2014 Q4	23.25 Thousand CAD	24.73%
2013 Q3	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 FY	159.94 Thousand CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q4	159.94 Thousand CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q1	- CAD	0.0%
2011 Q4	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q1	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q2	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q1	- CAD	100.0%
2009 Q3	- CAD	0.0%
2009 Q2	- CAD	0.0%
2008 FY	- CAD	-100.0%
2008 Q4	-22.4 Thousand CAD	-430.5%
2008 Q2	10.71 Thousand CAD	0.0%
2008 Q1	- CAD	-100.0%
2008 Q3	6780.00 CAD	-36.69%
2007 Q2	3514.00 CAD	-39.15%
2007 Q4	4230.00 CAD	16.3%
2007 Q3	3637.00 CAD	3.5%
2007 FY	17.15 Thousand CAD	-28.81%
2007 Q1	5775.00 CAD	-30.7%
2006 Q1	2921.00 CAD	0.0%
2006 FY	24.09 Thousand CAD	8.97%
2006 Q3	10.49 Thousand CAD	347.49%
2006 Q2	2346.00 CAD	-19.69%
2006 Q4	8333.00 CAD	-20.62%
2005 Q2	- CAD	-100.0%
2005 Q4	- CAD	0.0%
2005 FY	22.11 Thousand CAD	64.87%
2005 Q1	8873.00 CAD	137.76%
2005 Q3	- CAD	0.0%
2004 Q1	8902.00 CAD	-16.79%
2004 FY	13.41 Thousand CAD	-82.5%
2004 Q3	12.18 Thousand CAD	129.29%
2004 Q2	5316.00 CAD	-40.28%
2004 Q4	-23.5 Thousand CAD	-292.8%
2003 Q4	10.69 Thousand CAD	-25.63%
2003 FY	76.64 Thousand CAD	0.0%
2003 Q2	4694.00 CAD	0.0%
2003 Q3	14.38 Thousand CAD	206.43%

Peer Revenue Comparison of Kane Biotech Inc.

Name	Revenue	Revenue Difference
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	-94.083%
CSL Limited	14.69 Billion USD	99.999%
Eiger BioPharmaceuticals, Inc.	15.77 Million USD	99.055%
Nanobac Pharmaceuticals, Incorporated	17.62 Thousand USD	-745.468%
Institute of Biomedical Research Corp.	- USD	-Infinity%
Evofem Biosciences, Inc.	18.21 Million USD	99.182%
Santhera Pharmaceuticals Holding AG	122.95 Million USD	99.879%
Propanc Biopharma, Inc.	- USD	-Infinity%
Mesoblast Limited	5.9 Million USD	97.476%
Marizyme, Inc.	645.81 Thousand USD	76.931%
Genus plc	668.8 Million USD	99.978%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	63.678%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
ContraFect Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
IMV Inc.	- USD	-Infinity%
AXIM Biotechnologies, Inc.	39.51 Thousand USD	-276.993%
MultiCell Technologies, Inc.	49.32 USD	-301968.127%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	49.72 Million USD	99.7%
EV Biologics, Inc.	48.9 Thousand USD	-204.663%
Q BioMed Inc.	284.35 Thousand USD	47.607%
Emmaus Life Sciences, Inc.	29.59 Million USD	99.497%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	70 Thousand USD	-112.829%
Skye Bioscience, Inc.	- USD	-Infinity%
SQZ Biotechnologies Company	21.47 Million USD	99.306%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	75.72 Thousand USD	-96.741%
Intellipharmaceutics International Inc.	65.72 Thousand USD	-126.661%
Acro Biomedical Co., Ltd.	658.5 Thousand USD	77.376%
Neon Bloom, Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	245.31 Million USD	99.939%
Therapeutic Solutions International, Inc.	98.99 Thousand USD	-50.494%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	- USD	-Infinity%
argenx SE	1.22 Billion USD	99.988%
HST Global, Inc.	- USD	-Infinity%
Halberd Corporation	999.00 USD	-14812.913%
Enzolytics Inc.	52.79 Thousand USD	-182.18%
Resverlogix Corp.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
Nuo Therapeutics, Inc.	608.52 Thousand USD	75.518%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	1.93 Million USD	92.289%
American Oriental Bioengineering, Inc.	145.09 Million USD	99.897%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Provectus Biopharmaceuticals, Inc.	557.71 Thousand USD	73.287%
Endonovo Therapeutics, Inc.	140.24 Thousand USD	-6.231%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	617.38 Thousand USD	75.869%
ONE Bio Corp.	52.29 Million USD	99.715%
Zenith Capital Corp.	- USD	-Infinity%
Genscript Biotech Corporation	839.52 Million USD	99.982%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	- USD	-Infinity%
WPD Pharmaceuticals Inc.	- USD	-Infinity%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Helix BioMedix, Inc.	997.72 Thousand USD	85.068%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	48.35 Million USD	99.692%
BioStem Technologies, Inc.	16.68 Million USD	99.107%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	236.56 Thousand USD	37.022%
Regen BioPharma, Inc.	236.56 Thousand USD	37.022%
NovAccess Global Inc.	- USD	-Infinity%
Affymax, Inc.	1.36 Million USD	89.118%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	473.73 Thousand USD	68.552%
SYBLEU INC	11.69 Thousand USD	-1173.769%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
International Stem Cell Corporation	7.78 Million USD	98.087%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	13 Thousand USD	-1046.0%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	39.53 Thousand USD	-276.84%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	3.33 Million USD	95.526%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	6.66 Million USD	97.765%
IntelGenx Technologies Corp.	1.03 Million USD	85.661%
Gelesis Holdings, Inc.	25.76 Million USD	99.422%
CSL Limited	14.8 Billion USD	99.999%
Cellectis S.A.	755 Thousand USD	80.268%

Global Stocks Search

Kane Biotech Inc. (KNBIF)

Revenue Summary of Kane Biotech Inc.

Annual Revenue Chart of Kane Biotech Inc. (2023 - 2003)

Historical Annual Revenue of Kane Biotech Inc. (2023 - 2003)

Peer Revenue Comparison of Kane Biotech Inc.